MedTrace Logo

Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom

NCT00758173 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This study is looking at genetic susceptibility and the interactions between genes and the environment in patients with prostate cancer.

Conditions

Interventions

GENETIC

polymorphism analysis

OTHER

laboratory biomarker analysis

OTHER

questionnaire administration

Sponsors & Collaborators

Principal Investigators

  • Paul Pharoah, MD · Cancer Research UK

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00758173 on ClinicalTrials.gov